Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1186/s12885-017-3952-7
Published Online: 2018-01-02
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kaneda, Toshihiko
Yoshioka, Hiroshige
Tamiya, Motohiro
Tamiya, Akihiro
Hata, Akito
Okada, Asukaka
Niwa, Takashi
Shiroyama, Takayuki
Kanazu, Masaki
Ishida, Tadashi
Katakami, Nobuyuki